Single center experience with thymoglobulin in renal transplantation.
Zaltzman
J S
JS
Department of Medicine, St Michael's Hospital, University of Toronto, Ontario, Canada.
Paul
L C
LC
D000328:Adult; D000818:Animals; D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006084:Graft Rejection / Q000628:therapy; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007668:Kidney / Q000502:physiology; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D011817:Rabbits
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents